Skip to main content

Deeply committed to aortic treatment

Our purpose-built solutions address the unique needs of aortic treatment. See what distinguishes our aortic products, services and support, and the difference they can make for you and your patients.

Support Powerful products

Difference through support

Talking with support

Support you can count on   

  • 8+ years  –  Average field representatives’ tenure supporting Gore’s aortic devices, building on diverse clinical backgrounds
  • Non-commissioned sales force – our focus is on outcomes
  • From pre-case planning to procedural consultation we are by your side to provide support.

Advancing clinical care: GREAT study takeaways

“Gore is interested in patient outcomes and being a long-term partner with the healthcare provider to achieve what we are looking for.” 

-Gore Customer

Value analyses to help you improve patient experiences, reduce the cost of care, and bring to life a population health model

Value-based solutions

Difference through powerful products

Excluder Precise Delivery System

Ability to reposition to obtain optimal seal in AAA treatment

View animation

First EVAR stent graft to feature angulation control


See the deployment

First thoracic stent graft to feature controlled, staged deployment with optional angulation control 

See the deployment

Why Oversizing Matters Video Thumbnail

The only thoracic endograft engineered to perform in 6–33% oversizing conditions

Watch video

Products designed to work together

Download brochure

Internal iliac artery preservation

The recommended treatment1,2to sustain quality of life

Watch video

  1. Chaikof EL, Dalman RL, Eskandari MK, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. Journal of Vascular Surgery 2018;67(1):2-77.e2.
  2. Wanhainen A, et al., European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms. Eur J Vasc Endovasc Surg (2019) 57, 8-93.